Literature DB >> 31019701

Surveillance for individuals at high-risk of pancreatic cancer: Are we finally heading toward evidence?

Gabriele Capurso1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31019701      PMCID： PMC6466750          DOI： 10.1177/2050640619839528

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN： 2050-6406            Impact factor:   4.623


× No keyword cloud information.
  6 in total

Review 1.  Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results.

Authors:  Salvatore Paiella; Roberto Salvia; Matteo De Pastena; Tommaso Pollini; Luca Casetti; Luca Landoni; Alessandro Esposito; Giovanni Marchegiani; Giuseppe Malleo; Giulia De Marchi; Aldo Scarpa; Mirko D'Onofrio; Riccardo De Robertis; Teresa Lucia Pan; Laura Maggino; Stefano Andrianello; Erica Secchettin; Deborah Bonamini; Davide Melisi; Massimiliano Tuveri; Claudio Bassi
Journal:  Pancreatology       Date:  2018-04-10       Impact factor: 3.996

2.  Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry.

Authors:  Salvatore Paiella; Gabriele Capurso; Giulia Martina Cavestro; Giovanni Butturini; Raffaele Pezzilli; Roberto Salvia; Marianna Signoretti; Stefano Crippa; Silvia Carrara; Isabella Frigerio; Claudio Bassi; Massimo Falconi; Elsa Iannicelli; Alessandro Giardino; Alessandro Mannucci; Andrea Laghi; Luigi Laghi; Luca Frulloni; Alessandro Zerbi
Journal:  Am J Gastroenterol       Date:  2019-04       Impact factor: 10.864

3.  Pancreatic Juice Mutation Concentrations Can Help Predict the Grade of Dysplasia in Patients Undergoing Pancreatic Surveillance.

Authors:  Masaya Suenaga; Jun Yu; Koji Shindo; Koji Tamura; Jose Alejandro Almario; Christopher Zaykoski; P Dane Witmer; Shahriar Fesharakizadeh; Michael Borges; Anne-Marie Lennon; Eun-Ji Shin; Marcia Irene Canto; Michael Goggins
Journal:  Clin Cancer Res       Date:  2018-01-04       Impact factor: 12.531

4.  Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.

Authors:  Marcia Irene Canto; Jose Alejandro Almario; Richard D Schulick; Charles J Yeo; Alison Klein; Amanda Blackford; Eun Ji Shin; Abanti Sanyal; Gayane Yenokyan; Anne Marie Lennon; Ihab R Kamel; Elliot K Fishman; Christopher Wolfgang; Matthew Weiss; Ralph H Hruban; Michael Goggins
Journal:  Gastroenterology       Date:  2018-05-24       Impact factor: 22.682

5.  Diagnostic Yield From Screening Asymptomatic Individuals at High Risk for Pancreatic Cancer: A Meta-analysis of Cohort Studies.

Authors:  Juan E Corral; Karl F Mareth; Douglas L Riegert-Johnson; Ananya Das; Michael B Wallace
Journal:  Clin Gastroenterol Hepatol       Date:  2018-06-30       Impact factor: 11.382

Review 6.  Results of surveillance in individuals at high-risk of pancreatic cancer: A systematic review and meta-analysis.

Authors:  Marianna Signoretti; Marco J Bruno; Giulia Zerboni; Jan-Werner Poley; Gianfranco Delle Fave; Gabriele Capurso
Journal:  United European Gastroenterol J       Date:  2018-01-08       Impact factor: 4.623
  6 in total
  1 in total

1.  Diagnostic delay does not influence survival of pancreatic cancer patients.

Authors:  Caterina Stornello; Livia Archibugi; Serena Stigliano; Giuseppe Vanella; Benedetta Graglia; Carlo Capalbo; Giuseppe Nigri; Gabriele Capurso
Journal:  United European Gastroenterol J       Date:  2019-09-19       Impact factor: 4.623
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.